Skip to main content
. 2023 Feb 12;12(4):1467. doi: 10.3390/jcm12041467

Table 4.

Univariate logistic regression for mortality during COVID-19 pandemic.

Variables Survivors (n = 1051) Deaths (n = 137) p-Value OR (95% CI)
Age 60.87 ± 12.27753 69.59 ± 13.93396 <0.0001 1.86 (1.74 to 2.07)
Gender, n (%) female 274/1051 (26%) 56/137 (40.87%) <0.0001 1.95 (1.67, 2.79)
Anterior STEMI, n (%) 495/1051 (47.1%) 78/137 (56.93%) 0.002 2.36 (2.37, 3.29)
Arterial hypertension, n (%) 790/1051 (75.17%) 92/137 (67.15%) 0.04 2.03 (1.51, 2.73)
Diabetes mellitus, n (%) 295/1051 (28.07) 59/137 (43.06%) <0.0001 3.12 (2.57, 3.74)
Dyslipidemia, n (%) 865/1051 (82.3%) 69/137 (50.36%) <0.001 2.39 (2.11, 3.18)
Smoking status, n (%)
Smokers 546/1051 (51.95%) 30/137 (21.90%) <0.001 1.4 (1.1–1.8)
Ex-smokers 118/1051 (11.23%) 4/137 (2.92%) <0.001 1.2 (1.1–1.67)
History of IHD, n (%) 111/1051 (10.56%) 19/137 (13.86%) 0.002 2.27 (1.65, 2.95)
COVID-19 infection 64/1051 (6.09%) 25/137 (11.5%) <0.0001 1.67 (1.2–1.9)
LVEF 38.29 ± 9.0% 25.81% ± 12.08% <0.0001 0.79 (0.68, 0.95)
Need for mechanical ventilation, n (%) 17/1051 (1.62%) 123/137 (89.78%) <0.0001 58.92 (29.7, 83.27)
Coronary lesions, n (%) * <0.001
No coronary lesion 54/1051 (5.14%) 3/137 (2.19%)
One-vessel disease 635/1051 (60.42%) 45/137 (32.85%) 8.7. (4.2–12.3)
Two-vessel disease 250/1051 (23.79%) 29/204 (21.17%) 12.4 (10.2–20.6)
Three-vessel disease 91/1051 (8.66%) 23/137 (16.79%) 28.6 (19.56, 45.62)
Left main disease 21/1051 (1.99%) 37/137 (27.01%) 45.6 (29.67, 74.51)
Revascularization, n (%) ** <0.001
No PCI 106/1051 (10.08%) 50/137 (36.49%)
Primary PCI 749/1051 (71.26%) 71/137 (51.82%) 0.14 (0.08, 0.24)
Salvage PCI 154/1051 (14.65%) 9/137 (6.57%) 0.08 (0.01, 0.66)
Elective PCI 12/1051 (1.41%) 1/137 (0.72%) 0.09 (0.01, 0.66)
CABG 30/1051 (2.85%) 6/137 (4.38%) 4.41 (4.20, 5.86)

CABG—coronary artery bypass graft; CI—confidence intervals; IHD—ischemic heart disease; LVEF—left ventricular ejection fraction; OR—odd ratio; PCI—percutaneous coronary intervention; STEMI—ST-elevation myocardial infarction. * Reference group, no coronary lesions; ** reference group, no PCI.